Advanced Medical Isotope Corporation – Trademark Portfolio

Entity Type: 03

Advanced Medical Isotope Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ISOPET and RADIOGEL. The owner is based in Kennewick, WA.

6208 W. Okanogan Avenue

Kennewick, WA 99336

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RADIOGEL
RADIOGEL
Abandoned 2017
ISOPET
ISOPET
Registered 2016
RADIOGEL
RADIOGEL
Registered 2013

Trademark Classifications

Advanced Medical Isotope Corporation's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Advanced Medical Isotope Corporation have?

Advanced Medical Isotope Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Advanced Medical Isotope Corporation file in?

Advanced Medical Isotope Corporation files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Advanced Medical Isotope Corporation's most well-known trademarks?

Advanced Medical Isotope Corporation's registered trademark portfolio includes well-known marks such as ISOPET and RADIOGEL. These are among 2 currently registered trademarks in the portfolio.

What is Advanced Medical Isotope Corporation's trademark registration success rate?

Advanced Medical Isotope Corporation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.